Together, our findings uncover the USP10‐POLR2A‐SLC7A11 axis as a critical ferroptosis regulator, which possesses therapeutic potential and clinical value in patients with HNSCC. The gene discussed is POLR2A; the disease is head and neck squamous cell carcinoma.